BChE-IN-22
BChE-IN-22 (compound 5A) is a selective eqBChE inhibitor (IC50: 0.53 μM), has anti-inflammatory and neuroprotective activities. BChE-IN-22 can inhibit cell damage caused by Aβ25-35 (HY-P0128) and improve cognitive dysfunction caused by Scopolamine (HY-N0296) [1].
Product Specifications
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bche-in-22.html
Solubility
10 mM in DMSO
Smiles
CN(C(OC1=CC(OC(N(C)C)=O)=C(C=C1)C(N2CCC(CC2)CC3=CC=CC=C3)=O)=O)C
Molecular Formula
C25H31N3O5
Molecular Weight
453.53
References & Citations
[1]Zhou Y, et al. Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem. 2023 Dec;38 (1) :2231661.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6340897-01 0.2 mL
RBMY1A1, CT (RBMY1A1,RNA-binding motif protein, Y chromosome, family 1 member A1/C,RBM1, RBM2, YRRM1) (FITC)
Ask
View Details 
MBS6340897-02 5x 0.2 mL
RBMY1A1, CT (RBMY1A1,RNA-binding motif protein, Y chromosome, family 1 member A1/C,RBM1, RBM2, YRRM1) (FITC)
Ask
View Details 